{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:08:38Z","timestamp":1777903718846,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jaccas.2026.107542","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:52:25Z","timestamp":1776883945000},"page":"107542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Changing the Treatment Landscape in Amyloid Light Chain Cardiomyopathy"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3024-9563","authenticated-orcid":false,"given":"Lily K.","family":"Stern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Kittleson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccas.2026.107542_bib1","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis","volume":"81","author":"Kittleson Michelle","year":"2023","journal-title":"JACC"},{"key":"10.1016\/j.jaccas.2026.107542_bib2","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2025017073","article-title":"American Society of Hematology (ASH) 2026 guidelines on diagnosis of light chain amyloidosis","author":"Kukreti","year":"2026","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaccas.2026.107542_bib3","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.mayocp.2025.05.009","article-title":"Heart transplantation for cardiac amyloidosis: Mayo clinic consensus statement","volume":"100","author":"Lyle","year":"2025","journal-title":"Mayo Clinic Proc"},{"key":"10.1016\/j.jaccas.2026.107542_bib4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cardfail.2024.08.046","article-title":"Cardio-oncology and heart failure: AL amyloidosis for the heart failure clinician: a supplement to the scientific statement from the heart failure society of America","volume":"31","author":"Bloom","year":"2025","journal-title":"J Card Fail"},{"key":"10.1016\/j.jaccas.2026.107542_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaccas.2026.107542_bib6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJMoa2514663","article-title":"Teclistamab plus daratumumab in relapsed or refractory multiple myeloma","volume":"394","author":"Costa","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaccas.2026.107542_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMoa2203478","article-title":"Teclistamab in relapsed or refractory multiple myeloma","volume":"387","author":"Moreau","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaccas.2026.107542_bib8","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1182\/blood.2023022937","article-title":"Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series","volume":"143","author":"Forgeard","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jaccas.2026.107542_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/ejh.14348","article-title":"Safety and efficacy of teclistamab in patients with relapsed or refractory AL amyloidosis","volume":"114","author":"Stalker","year":"2025","journal-title":"Eur J Haematol"},{"issue":"16","key":"10.1016\/j.jaccas.2026.107542_bib10","article-title":"Teclistamab treatment followed by heart transplantation for advanced immunoglobulin light chain amyloid cardiomyopathy","volume":"31","author":"Ibrahim","year":"2026","journal-title":"JACC Case Rep"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084926006947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084926006947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:06:27Z","timestamp":1777637187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084926006947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":10,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2666084926006947"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2026.107542","relation":{},"ISSN":["2666-0849"],"issn-type":[{"value":"2666-0849","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changing the Treatment Landscape in Amyloid Light Chain Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2026.107542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2026.107479","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"107542"}}